Results 101 to 110 of about 955 (158)

Breast Cancer Therapy by Small-Molecule Reactivation of Mutant p53. [PDF]

Curr Oncol
Slight SH, Hyder SM.
europepmc   +1 more source

Improving cancer therapy with new p53-activating agents [PDF]

, 2019
Rute de Fátima Azevedo Pinheiro
core  

Integrating Functional Genomic Screens and Multi-Omics Data to Construct a Prognostic Model for Lung Adenocarcinoma and Validating SPC25. [PDF]

Cancers (Basel)
Zhang Y, Tan H, Jiang D.
europepmc   +1 more source

Waldenström Macroglobulinemia: The Role of TP53 Mutations in Disease Progression and Therapeutic Response. [PDF]

Curr Issues Mol Biol
Kampitsi DD, Theotokis P, Evangelidis P, Meditskou S, Manthou ME, Dermitzakis I.   +5 more
europepmc   +1 more source

Targeting p53 in anticancer therapy: Searching for new small molecule activators. [PDF]

, 2018
Beatriz Sampaio da Silva
core  

Erratum for: Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53

Cellular Physiology and Biochemistry, 2020
openaire   +1 more source

Honoring Daniel Aberdam's scientific and human legacy. [PDF]

Cell Death Dis
Blanpain C, Candi E, Gandarillas A, Melino G, Piacentini M, Shalom-Feuerstein R.   +5 more
europepmc   +1 more source

Daniel Aberdam, the legacy of a mentor. [PDF]

Cell Death Differ
Zhou H, Attali B, Lagali N, Shalom-Feuerstein R.   +3 more
europepmc   +1 more source

DNA methylation and transcription factor-driven immune subtypes in ovarian cancer. [PDF]

Discov Oncol
Hu J, Su M, Qin Z, Li J, Wang H, Chang K, He G, Zhang Y, Chen X.   +8 more
europepmc   +1 more source

Seeking for new p53-activating agents: effective therapies for colorectal cancer [PDF]

, 2020
Helena Isabel Nogueira Ramos Rocha
core